Literature DB >> 22901745

Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.

Adam C Riegel1, Jeffrey Antone, David L Schwartz.   

Abstract

To compare relative carotid and normal tissue sparing using volumetric-modulated arc therapy (VMAT) or intensity-modulated radiation therapy (IMRT) for early-stage larynx cancer. Seven treatment plans were retrospectively created on 2 commercial treatment planning systems for 11 consecutive patients with T1-2N0 larynx cancer. Conventional plans consisted of opposed-wedged fields. IMRT planning used an anterior 3-field beam arrangement. Two VMAT plans were created, a full 360° arc and an anterior 180° arc. Given planning target volume (PTV) coverage of 95% total volume at 95% of 6300 cGy and maximum spinal cord dose below 2500 cGy, mean carotid artery dose was pushed as low as possible for each plan. Deliverability was assessed by comparing measured and planned planar dose with the gamma (γ) index. Full-arc planning provided the most effective carotid sparing but yielded the highest mean normal tissue dose (where normal tissue was defined as all soft tissue minus PTV). Static IMRT produced next-best carotid sparing with lower normal tissue dose. The anterior half-arc produced the highest carotid artery dose, in some cases comparable with conventional opposed fields. On the whole, carotid sparing was inversely related to normal tissue dose sparing. Mean γ indexes were much less than 1, consistent with accurate delivery of planned treatment. Full-arc VMAT yields greater carotid sparing than half-arc VMAT. Limited-angle IMRT remains a reasonable alternative to full-arc VMAT, given its ability to mediate the competing demands of carotid and normal tissue dose constraints. The respective clinical significance of carotid and normal tissue sparing will require prospective evaluation.
Copyright © 2013 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22901745     DOI: 10.1016/j.meddos.2012.07.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  6 in total

1.  Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

Authors:  J-Y Lu; L-L Wu; J-Y Zhang; J Zheng; M L-M Cheung; C-C Ma; L-X Xie; B-T Huang
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

Review 2.  Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.

Authors:  D M Gujral; M Long; J W G Roe; K J Harrington; C M Nutting
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-11-01       Impact factor: 4.126

3.  Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Authors:  Stefan Janssen; Christoph Glanzmann; Gerhard Huber; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-06-13       Impact factor: 3.481

4.  Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer.

Authors:  Young Suk Kim; Jaegi Lee; Jong In Park; Wonmo Sung; Sol Min Lee; Gwi Eon Kim
Journal:  Radiat Oncol J       Date:  2016-03-30

5.  Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis.

Authors:  Eun Seok Kim; Seung-Gu Yeo
Journal:  Oncol Lett       Date:  2014-04-04       Impact factor: 2.967

6.  Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.

Authors:  Chae-Seon Hong; Dongryul Oh; Sang Gyu Ju; Yong Chan Ahn; Jae Myoung Noh; Kwangzoo Chung; Jin Sung Kim; Tae-Suk Suh
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.